Codexis, Inc.

Codexis, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.

Company Details

Employees
254
Founded
-
Address
200 Penobscot Drive, Redwood City,ca 94063,united States
Phone
650-421-8100
Email
Sa****@****xis.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Redwood City, CA
Looking for a particular Codexis, Inc. employee's phone or email?

Codexis, Inc. Questions

News

Codexis to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewswire

Codexis to Report Third Quarter 2025 Financial Results on November 6 GlobeNewswire

Codexis, Inc. to Report Third Quarter 2025 Financial Results on November 6 - Quiver Quantitative

Codexis, Inc. to Report Third Quarter 2025 Financial Results on November 6 Quiver Quantitative

Codexis (NASDAQ: CDXS) sets third quarter results call and webcast Nov. 6 at 4:30 pm ET - Stock Titan

Codexis (NASDAQ: CDXS) sets third quarter results call and webcast Nov. 6 at 4:30 pm ET Stock Titan

Codexis Reports Second Quarter 2025 Financial Results - Yahoo Finance

Codexis Reports Second Quarter 2025 Financial Results Yahoo Finance

Codexis, Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq

Codexis, Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 Nasdaq

Enzymatic Solutions Leader Codexis to Showcase at Major Healthcare Conference in New York This September - Stock Titan

Enzymatic Solutions Leader Codexis to Showcase at Major Healthcare Conference in New York This September Stock Titan

Codexis Reports First Quarter 2025 Financial Results - Yahoo Finance

Codexis Reports First Quarter 2025 Financial Results Yahoo Finance

Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference Stock Titan

Codexis to Participate in Cantor Global Healthcare Conference - GlobeNewswire

Codexis to Participate in Cantor Global Healthcare Conference GlobeNewswire

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - Yahoo Finance

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services Yahoo Finance

Codexis Appoints Christos Richards to Board of Directors - GlobeNewswire

Codexis Appoints Christos Richards to Board of Directors GlobeNewswire

Codexis’ Landmark Presentations at TIDES USA Highlight - GlobeNewswire

Codexis’ Landmark Presentations at TIDES USA Highlight GlobeNewswire

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference GlobeNewswire

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewswire

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics GlobeNewswire

Codexis Announces New Employment Inducement Grants - Yahoo Finance

Codexis Announces New Employment Inducement Grants Yahoo Finance

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award - Yahoo Finance

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award Yahoo Finance

Enhancing the Imine Reductase Activity of a Promiscuous Glucose Dehydrogenase for Scalable Manufacturing of a Chiral Neprilysin Inhibitor Precursor - ACS Publications

Enhancing the Imine Reductase Activity of a Promiscuous Glucose Dehydrogenase for Scalable Manufacturing of a Chiral Neprilysin Inhibitor Precursor ACS Publications

Codexis to Participate in Upcoming Healthcare Conferences - Stock Titan

Codexis to Participate in Upcoming Healthcare Conferences Stock Titan

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board - GlobeNewswire

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board GlobeNewswire

With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo Finance

With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing Yahoo Finance

Codexis Weighs ECO Scale As Cash Runway Tightens (NASDAQ:CDXS) - Seeking Alpha

Codexis Weighs ECO Scale As Cash Runway Tightens (NASDAQ:CDXS) Seeking Alpha

Engineering an Amine Transaminase for the Efficient Production of a Chiral Sacubitril Precursor - ACS Publications

Engineering an Amine Transaminase for the Efficient Production of a Chiral Sacubitril Precursor ACS Publications

Enzyme engineer Codexis cuts short several programs, lays off 18% of staff - Fierce Biotech

Enzyme engineer Codexis cuts short several programs, lays off 18% of staff Fierce Biotech

Crosswalk picks up Fabry, Pompe compounds from abandoned Takeda, Codexis collab - Fierce Biotech

Crosswalk picks up Fabry, Pompe compounds from abandoned Takeda, Codexis collab Fierce Biotech

Enzyme Engineering Market Size, Report by 2034 - Precedence Research

Enzyme Engineering Market Size, Report by 2034 Precedence Research

Enzyme engineering firm Codexis names new CEO - drugdiscoverytrends.com

Enzyme engineering firm Codexis names new CEO drugdiscoverytrends.com

Engineering an Amine Transaminase for the Efficient Production of a Chiral Sacubitril Precursor - ACS Publications

Engineering an Amine Transaminase for the Efficient Production of a Chiral Sacubitril Precursor ACS Publications

Codexis Signs Licensing Agreement with Tate & Lyle - Prepared Foods magazine

Codexis Signs Licensing Agreement with Tate & Lyle Prepared Foods magazine

Purolite and Codexis Announce Collaboration to Develop and Market Immobilized Enzymes for Pharmaceut - AOL.com

Purolite and Codexis Announce Collaboration to Develop and Market Immobilized Enzymes for Pharmaceut AOL.com

Directed evolution of an ultrastable carbonic anhydrase for highly efficient carbon capture from flue gas - PNAS

Directed evolution of an ultrastable carbonic anhydrase for highly efficient carbon capture from flue gas PNAS

CDXS Stock Price and Chart — NASDAQ:CDXS - TradingView

CDXS Stock Price and Chart — NASDAQ:CDXS TradingView

Codexis Undergoes Its Own Evolution - Chemical & Engineering News

Codexis Undergoes Its Own Evolution Chemical & Engineering News

Top Codexis, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant